{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:23:23Z","timestamp":1791897803820,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1038\/sj.bjc.6602772","type":"journal-article","created":{"date-parts":[[2005,10,13]],"date-time":"2005-10-13T03:36:46Z","timestamp":1129174606000},"page":"678-687","source":"Crossref","is-referenced-by-count":386,"title":["Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats"],"prefix":"10.1038","volume":"93","author":[{"given":"H","family":"Uchino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Negishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kakizoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,9,13]]},"reference":[{"key":"BF6602772_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0165-6147(94)90314-X","volume":"15","author":"TM Allen","year":"1994","unstructured":"Allen TM (1994) Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends Pharmacol Sci 15: 215\u2013220","journal-title":"Trends Pharmacol Sci"},{"key":"BF6602772_CR2","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/(SICI)1097-0142(19971115)80:10<1966::AID-CNCR14>3.0.CO;2-W","volume":"80","author":"J Bellmunt","year":"1997","unstructured":"Bellmunt J, Ribas A, Eres N, Albanell J, Almanza C, Bermejo B, Sole LA, Baselga J (1997) Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma. Cancer 80: 1966\u20131972","journal-title":"Cancer"},{"key":"BF6602772_CR3","first-page":"559","volume":"11","author":"T Boulikas","year":"2004","unstructured":"Boulikas T, Vougiouka M (2004) Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (review). Oncol Rep 11: 559\u2013595","journal-title":"Oncol Rep"},{"key":"BF6602772_CR4","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1200\/JCO.2004.11.069","volume":"22","author":"J Cassidy","year":"2004","unstructured":"Cassidy J, Tabernero J, Twelves C, Brunet R, Butts C, Conroy T, Debraud F, Figer A, Grossmann J, Sawada N, Schoffski P, Sobrero A, Van Cutsem E, Diaz-Rubio E (2004) XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer. J Clin Oncol 22: 2084\u20132091","journal-title":"J Clin Oncol"},{"key":"BF6602772_CR5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/BF00227662","volume":"84","author":"G Cavaletti","year":"1992","unstructured":"Cavaletti G, Tredici G, Marmiroli P, Petruccioli MG, Barajon I, Fabbrica D (1992) Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats. Acta Neuropathol (Berl) 84: 364\u2013371","journal-title":"Acta Neuropathol (Berl)"},{"key":"BF6602772_CR6","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S0300-9084(78)80568-9","volume":"60","author":"MJ Cleare","year":"1978","unstructured":"Cleare MJ, Hydes PC, Malerbi BW, Watkins DM (1978) Anti-tumor platinum complexes: relationships between chemical properties and activity. Biochimie 60: 835\u2013850","journal-title":"Biochimie"},{"key":"BF6602772_CR7","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1093\/jnci\/djg036","volume":"95","author":"A du Bois","year":"2003","unstructured":"du Bois A, Luck HJ, Meier W, Adams HP, Mobus V, Costa S, Bauknecht T, Richter B, Warm M, Schroder W, Olbricht S, Nitz U, Jackisch C, Emons G, Wagner U, Kuhn W, Pfisterer J (2003) A randomized clinical trial of cisplatin\/paclitaxel versus carboplatin\/paclitaxel as first-line treatment of ovarian cancer. J Natl Cancer Inst 95: 1320\u20131329","journal-title":"J Natl Cancer Inst"},{"key":"BF6602772_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3109\/10611869608996830","volume":"3","author":"A Gabizon","year":"1996","unstructured":"Gabizon A, Chemla M, Tzemach D, Horowitz AT, Goren D (1996) Liposome longevity and stability in circulation: effects on the in vivo delivery to tumors and therapeutic efficacy of encapsulated anthracyclines. J Drug Target 3: 391\u2013398","journal-title":"J Drug Target"},{"key":"BF6602772_CR9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1200\/JCO.1992.10.5.795","volume":"10","author":"RW Gregg","year":"1992","unstructured":"Gregg RW, Molepo JM, Monpetit VJ, Mikael NZ, Redmond D, Gadia M, Stewart DJ (1992) Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity. J Clin Oncol 10: 795\u2013803","journal-title":"J Clin Oncol"},{"key":"BF6602772_CR10","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/sj.bjc.6602479","volume":"92","author":"T Hamaguchi","year":"2005","unstructured":"Hamaguchi T, Matsumura Y, Suzuki M, Shimizu K, Goda R, Nakamura I, Nakatomi I, Yokoyama M, Kataoka K, Kakizoe T (2005) NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel. Br J Cancer 92: 1240\u20131246","journal-title":"Br J Cancer"},{"key":"BF6602772_CR11","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1200\/JCO.1997.15.5.1844","volume":"15","author":"A Horwich","year":"1997","unstructured":"Horwich A, Sleijfer DT, Fossa SD, Kaye SB, Oliver RT, Cullen MH, Mead GM, de Wit R, de Mulder PH, Dearnaley DP, Cook PA, Sylvester RJ, Stenning SP (1997) Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council\/European Organization for Research and Treatment of Cancer Trial. J Clin Oncol 15: 1844\u20131852","journal-title":"J Clin Oncol"},{"key":"BF6602772_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/0005-2736(91)90385-L","volume":"1062","author":"AL Klibanov","year":"1991","unstructured":"Klibanov AL, Maruyama K, Beckerleg AM, Torchilin VP, Huang L (1991) Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim Biophys Acta 1062: 142\u2013148","journal-title":"Biochim Biophys Acta"},{"key":"BF6602772_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0014-5793(90)81016-H","volume":"268","author":"AL Klibanov","year":"1990","unstructured":"Klibanov AL, Maruyama K, Torchilin VP, Huang L (1990) Amphipathic polyethylene glycols effectively prolong the circulation time of liposomes. FEBS Lett 268: 235\u2013237","journal-title":"FEBS Lett"},{"key":"BF6602772_CR14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/380561a0","volume":"380","author":"DD Lasic","year":"1996","unstructured":"Lasic DD (1996) Doxorubicin in sterically stabilized liposomes. Nature 380: 561\u2013562","journal-title":"Nature"},{"key":"BF6602772_CR15","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/0277-5379(82)90116-X","volume":"18","author":"FA Levi","year":"1982","unstructured":"Levi FA, Hrushesky WJ, Halberg F, Langevin TR, Haus E, Kennedy BJ (1982) Lethal nephrotoxicity and hematologic toxicity of cis-diamminedichloroplatinum ameliorated by optimal circadian timing and hydration. Eur J Cancer Clin Oncol 18: 471\u2013477","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF6602772_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0065-2571(00)00013-3","volume":"41","author":"H Maeda","year":"2001","unstructured":"Maeda H (2001) The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 41: 189\u2013207","journal-title":"Adv Enzyme Regul"},{"key":"BF6602772_CR17","first-page":"193","volume":"6","author":"H Maeda","year":"1989","unstructured":"Maeda H, Matsumura Y (1989) Tumoritropic and lymphotropic principles of macromolecular drugs. Crit Rev Ther Drug Carrier Syst 6: 193\u2013210","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"BF6602772_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","volume":"65","author":"H Maeda","year":"2000","unstructured":"Maeda H, Wu J, Sawa T, Matsumura Y, Hori K (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Rel 65: 271\u2013284","journal-title":"J Control Rel"},{"key":"BF6602772_CR19","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1038\/sj.bjc.6602204","volume":"91","author":"Y Matsumura","year":"2004","unstructured":"Matsumura Y, Hamaguchi T, Ura T, Muro K, Yamada Y, Shimada Y, Shirao K, Okusaka T, Ueno H, Ikeda M, Watanabe N (2004) Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br J Cancer 91: 1775\u20131781","journal-title":"Br J Cancer"},{"key":"BF6602772_CR20","first-page":"6387","volume":"46","author":"Y Matsumura","year":"1986","unstructured":"Matsumura Y, Maeda H (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46: 6387\u20136392","journal-title":"Cancer Res"},{"key":"BF6602772_CR21","first-page":"629","volume":"54","author":"MJ McKeage","year":"1994","unstructured":"McKeage MJ, Boxall FE, Jones M, Harrap KR (1994) Lack of neurotoxicity of oral bisacetatoamminedichlorocyclohexylamine-platinum(IV) in comparison to cisplatin and tetraplatin in the rat. Cancer Res 54: 629\u2013631","journal-title":"Cancer Res"},{"issue":"6","key":"BF6602772_CR22","first-page":"883","volume":"20","author":"C Meijer","year":"1999","unstructured":"Meijer C, de Vries EG, Marmiroli P, Tredici G, Frattola L, Cavaletti G (1999) Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy. Neurotoxicology 20 (6): 883\u2013887","journal-title":"Neurotoxicology"},{"key":"BF6602772_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0168-3659(01)00314-5","volume":"74","author":"N Nishiyama","year":"2001","unstructured":"Nishiyama N, Kataoka K (2001) Preparation and characterization of size-controlled polymeric micelle containing cis-dichlorodiammineplatinum(II) in the core. J Control Rel 74: 83\u201394","journal-title":"J Control Rel"},{"key":"BF6602772_CR24","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1023\/A:1010908916184","volume":"18","author":"N Nishiyama","year":"2001","unstructured":"Nishiyama N, Kato Y, Sugiyama Y, Kataoka K (2001) Cisplatin-loaded polymer\u2013metal complex micelle with time-modulated decaying property as a novel drug delivery system. Pharm Res 18: 1035\u20131041","journal-title":"Pharm Res"},{"key":"BF6602772_CR25","first-page":"8977","volume":"63","author":"N Nishiyama","year":"2003","unstructured":"Nishiyama N, Okazaki S, Cabral H, Miyamoto M, Kato Y, Sugiyama Y, Nishio K, Matsumura Y, Kataoka K (2003) Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res 63: 8977\u20138983","journal-title":"Cancer Res"},{"key":"BF6602772_CR26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1021\/la980572l","volume":"15","author":"N Nishiyama","year":"1999","unstructured":"Nishiyama N, Yokoyama M, Aoyagi T, Okano T, Sakurai Y, Kataoka K (1999) Preparation and characterization of self-assembled polymer\u2013metal complex micelle from cis-dichlorodiammineplatinum(II) and poly(ethylene glycol)-poly(\u03b1,\u03b2-aspartic acid) block copolymer in an aqueous medium. Langmuir 15: 377\u2013383","journal-title":"Langmuir"},{"key":"BF6602772_CR27","first-page":"549","volume":"12","author":"M Orditura","year":"2004","unstructured":"Orditura M, Quaglia F, Morgillo F, Martinelli E, Lieto E, De Rosa G, Comunale D, Diadema MR, Ciardiello F, Catalano G, De Vita F (2004) Pegylated liposomal doxorubicin: pharmacologic and clinical evidence of potent antitumor activity with reduced anthracycline-induced cardiotoxicity (review). Oncol Rep 12: 549\u2013556","journal-title":"Oncol Rep"},{"key":"BF6602772_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00686277","volume":"35","author":"V Pinzani","year":"1994","unstructured":"Pinzani V, Bressolle F, Haug IJ, Galtier M, Blayac JP, Balmes P (1994) Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review. Cancer Chemother Pharmacol 35: 1\u20139","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF6602772_CR29","first-page":"633","volume":"23","author":"BJ Roth","year":"1996","unstructured":"Roth BJ (1996) Chemotherapy for advanced bladder cancer. Semin Oncol 23: 633\u2013644","journal-title":"Semin Oncol"},{"key":"BF6602772_CR30","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1054\/bjoc.1999.1026","volume":"82","author":"D Screnci","year":"2000","unstructured":"Screnci D, McKeage MJ, Galettis P, Hambley TW, Palmer BD, Baguley BC (2000) Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs. Br J Cancer 82: 966\u2013972","journal-title":"Br J Cancer"},{"key":"BF6602772_CR31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1006\/exnr.1999.7174","volume":"159","author":"G Tredici","year":"1999","unstructured":"Tredici G, Braga M, Nicolini G, Miloso M, Marmiroli P, Schenone A, Nobbio L, Frattola L, Cavaletti G (1999) Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats. Exp Neurol 159: 551\u2013558","journal-title":"Exp Neurol"},{"key":"BF6602772_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1023\/A:1005756023082","volume":"36","author":"G Tredici","year":"1998","unstructured":"Tredici G, Tredici S, Fabbrica D, Minoia C, Cavaletti G (1998) Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration. J Neurooncol 36: 31\u201340","journal-title":"J Neurooncol"},{"key":"BF6602772_CR33","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/1097-0142(19901015)66:8<1697::AID-CNCR2820660808>3.0.CO;2-G","volume":"66","author":"RG van der Hoop","year":"1990","unstructured":"van der Hoop RG, van der Burg ME, ten Bokkel Huinink WW, van Houwelingen C, Neijt JP (1990) Incidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatin. Cancer 66: 1697\u20131702","journal-title":"Cancer"},{"key":"BF6602772_CR34","doi-asserted-by":"crossref","unstructured":"UKCCCR, PO Box 123, Kincolin\u2019s Inn Fields, London, WC2A 3PX (1998) United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (second edition). Br J Cancer 77: 1\u201310","DOI":"10.1038\/bjc.1998.1"},{"key":"BF6602772_CR35","first-page":"1693","volume":"50","author":"M Yokoyama","year":"1990","unstructured":"Yokoyama M, Miyauchi M, Yamada N, Okano T, Sakurai Y, Kataoka K, Inoue S (1990) Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res 50: 1693\u20131700","journal-title":"Cancer Res"},{"key":"BF6602772_CR36","first-page":"3229","volume":"51","author":"M Yokoyama","year":"1991","unstructured":"Yokoyama M, Okano T, Sakurai Y, Ekimoto H, Shibazaki C, Kataoka K (1991) Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res 51: 3229\u20133236","journal-title":"Cancer Res"},{"key":"BF6602772_CR37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3109\/10611869909085500","volume":"7","author":"M Yokoyama","year":"1999","unstructured":"Yokoyama M, Okano T, Sakurai Y, Fukushima S, Okamoto K, Kataoka K (1999) Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system. J Drug Target 7: 171\u2013186","journal-title":"J Drug Target"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6602772.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6602772","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6602772.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T08:18:00Z","timestamp":1684397880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6602772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["BF6602772"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6602772","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}